Biomx Ltd (PHGE)

$5.71 -0.52 (-8.35%)
Market Cap 8.73M
Revenue (ttm) 0.00
Net Income (ttm) -17.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 98,300
Avg Vol 1,235,826
Day's Range N/A - N/A
Shares Out 1.53M
Stochastic %K 50%
Beta 1.60
Analysts Sell
Price Target $26.00

Company Profile

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by P...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 2394 2377
Address:
22 Einstein Street, Floor 4, Ness Ziona, Israel
runningforthelongroad
runningforthelongroad Feb. 3 at 4:07 PM
$PHGE lets fly!
0 · Reply
nerowinger
nerowinger Feb. 3 at 2:42 PM
$PHGE morning dip
0 · Reply
simplifocused
simplifocused Feb. 3 at 1:37 PM
$PHGE nfa$50
0 · Reply
Victory777777
Victory777777 Feb. 2 at 10:58 PM
$PHGE $50
0 · Reply
fasteddiecakes
fasteddiecakes Feb. 2 at 9:44 PM
$DVLT $GITS $PHGE Lets see wich one is the next $BNAI I love chasing high short interest stocks, never mad so much money in my life.
0 · Reply
nerowinger
nerowinger Feb. 2 at 9:08 PM
$PHGE added
0 · Reply
WallyWin
WallyWin Feb. 2 at 6:28 PM
$PHGE
0 · Reply
forsiz1
forsiz1 Feb. 2 at 5:03 PM
$PHGE 20 soon 🚀 Patience folks
0 · Reply
WallyWin
WallyWin Feb. 2 at 4:48 PM
$PHGE
0 · Reply
WallyWin
WallyWin Feb. 2 at 4:46 PM
$PHGE 5000% $MGLD $TWNP $SPHL
0 · Reply
Latest News on PHGE
BiomX Issues Statement Regarding Recent Common Stock Trading Activity

Jan 27, 2026, 1:41 PM EST - 7 days ago

BiomX Issues Statement Regarding Recent Common Stock Trading Activity

BiomX Announces $3.0 Million Private Placement

Dec 29, 2025, 8:00 AM EST - 5 weeks ago

BiomX Announces $3.0 Million Private Placement

BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review

Nov 26, 2025, 1:23 PM EST - 2 months ago

BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

Nov 25, 2025, 4:40 PM EST - 2 months ago

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

BiomX Inc. (PHGE) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 10:31 AM EST - 2 months ago

BiomX Inc. (PHGE) Q3 2025 Earnings Call Transcript

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Nov 12, 2025, 7:30 AM EST - 2 months ago

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

Oct 17, 2025, 8:30 AM EDT - 3 months ago

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

Aug 19, 2025, 8:19 AM EDT - 6 months ago

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 11:48 AM EDT - 6 months ago

BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Aug 13, 2025, 6:30 AM EDT - 6 months ago

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Aug 6, 2025, 8:30 AM EDT - 6 months ago

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

Jul 14, 2025, 9:00 AM EDT - 7 months ago

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

Jul 8, 2025, 8:30 AM EDT - 7 months ago

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

May 19, 2025, 10:02 AM EDT - 9 months ago

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

BiomX Inc. (PHGE) Q1 2025 Earnings Conference Call Transcript

May 15, 2025, 4:57 PM EDT - 9 months ago

BiomX Inc. (PHGE) Q1 2025 Earnings Conference Call Transcript

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

May 15, 2025, 6:30 AM EDT - 9 months ago

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

May 8, 2025, 7:00 AM EDT - 9 months ago

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

Apr 1, 2025, 6:30 AM EDT - 11 months ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Mar 31, 2025, 6:30 AM EDT - 11 months ago

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Mar 25, 2025, 6:30 AM EDT - 11 months ago

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Mar 19, 2025, 12:35 PM EDT - 11 months ago

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

BiomX Inc. (PHGE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 10:20 AM EST - 1 year ago

BiomX Inc. (PHGE) Q3 2024 Earnings Call Transcript

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

Nov 14, 2024, 6:30 AM EST - 1 year ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Nov 12, 2024, 12:20 PM EST - 1 year ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

BiomX Announces a Mandatory Unit Separation

Oct 15, 2024, 7:00 AM EDT - 1 year ago

BiomX Announces a Mandatory Unit Separation

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 18, 2024, 8:00 AM EDT - 1 year ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 16, 2024, 10:55 AM EDT - 1 year ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

BiomX Inc. (PHGE) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 12:03 PM EDT - 1 year ago

BiomX Inc. (PHGE) Q2 2024 Earnings Call Transcript

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 6:30 AM EDT - 1 year ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 15, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Aug 8, 2024, 7:00 AM EDT - 1 year ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Top 3 Health Care Stocks That May Explode In Q3

Jul 31, 2024, 7:35 AM EDT - 1 year ago

Top 3 Health Care Stocks That May Explode In Q3

DXCM EW

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 29, 2024, 7:00 AM EDT - 1 year ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

Jul 10, 2024, 6:30 AM EDT - 1 year ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

May 30, 2024, 4:50 PM EDT - 1 year ago

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

May 30, 2024, 7:00 AM EDT - 1 year ago

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

BiomX (PHGE) Q1 2024 Earnings Call Transcript

May 21, 2024, 10:25 AM EDT - 1 year ago

BiomX (PHGE) Q1 2024 Earnings Call Transcript

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

May 21, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

May 15, 2024, 7:00 AM EDT - 1 year ago

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Apr 23, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

BiomX Announces the Appointment of Susan Blum to its Board of Directors

Apr 18, 2024, 8:00 AM EDT - 1 year ago

BiomX Announces the Appointment of Susan Blum to its Board of Directors

BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript

Apr 3, 2024, 12:26 PM EDT - 1 year ago

BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Apr 3, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

Mar 27, 2024, 6:30 AM EDT - 2 years ago

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Mar 18, 2024, 6:30 AM EDT - 2 years ago

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Mar 6, 2024, 7:30 AM EST - 2 years ago

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

Jan 4, 2024, 8:00 AM EST - 2 years ago

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023

Nov 30, 2023, 4:15 PM EST - 2 years ago

BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023

runningforthelongroad
runningforthelongroad Feb. 3 at 4:07 PM
$PHGE lets fly!
0 · Reply
nerowinger
nerowinger Feb. 3 at 2:42 PM
$PHGE morning dip
0 · Reply
simplifocused
simplifocused Feb. 3 at 1:37 PM
$PHGE nfa$50
0 · Reply
Victory777777
Victory777777 Feb. 2 at 10:58 PM
$PHGE $50
0 · Reply
fasteddiecakes
fasteddiecakes Feb. 2 at 9:44 PM
$DVLT $GITS $PHGE Lets see wich one is the next $BNAI I love chasing high short interest stocks, never mad so much money in my life.
0 · Reply
nerowinger
nerowinger Feb. 2 at 9:08 PM
$PHGE added
0 · Reply
WallyWin
WallyWin Feb. 2 at 6:28 PM
$PHGE
0 · Reply
forsiz1
forsiz1 Feb. 2 at 5:03 PM
$PHGE 20 soon 🚀 Patience folks
0 · Reply
WallyWin
WallyWin Feb. 2 at 4:48 PM
$PHGE
0 · Reply
WallyWin
WallyWin Feb. 2 at 4:46 PM
$PHGE 5000% $MGLD $TWNP $SPHL
0 · Reply
topstockalerts
topstockalerts Feb. 2 at 4:45 PM
$PHGE Relative strength remains high. Buyers continue to support price on pullbacks. This trend is intact.
1 · Reply
IAmMsMoneyMaker
IAmMsMoneyMaker Feb. 2 at 4:26 PM
$PHGE Ready to EXPLODE to the UPSIDE!🥳 Also… JUST A MATTER OF TIME… ⏳ ⌛️ $APVO $FUSE $ECDA
0 · Reply
dinoz1001
dinoz1001 Feb. 2 at 3:44 PM
$PHGE Looking good
0 · Reply
Canadiana
Canadiana Feb. 2 at 3:40 PM
$PHGE
0 · Reply
Sr2841
Sr2841 Feb. 2 at 1:13 PM
$MGLD $PHGE $SEGG $SPHL $TWNP 🚀🚀⬆️⬆️⬆️
0 · Reply
Victory777777
Victory777777 Feb. 2 at 1:09 PM
$PHGE 5000% $MGLD $PHGE $SEGG $SPHL $TWNP
0 · Reply
Victory777777
Victory777777 Feb. 2 at 1:08 PM
$PHGE
0 · Reply
simplifocused
simplifocused Feb. 2 at 12:31 PM
$PHGE It's coming, see short interest skyrocketing: NFA
0 · Reply
Avocado_smash
Avocado_smash Feb. 2 at 4:41 AM
$PHGE MY PT +/- in the next 2 weeks, imo only: 3.14--
0 · Reply
simplifocused
simplifocused Jan. 31 at 7:56 PM
$PHGE Looking for the next $TCGL , NFA
0 · Reply
simplifocused
simplifocused Jan. 31 at 1:50 PM
$TCGL Which proper squeeze is next? Can it be $PHGE or $FGI or $RGC or SMX or MLEC or TGL ++++ which ticker will they pick next? NFA
0 · Reply
InTheMoney_
InTheMoney_ Jan. 31 at 1:24 AM
$PHGE you only get bad news
0 · Reply